Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Abstract
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis. Chronic inflammatory processes affect all stages of tumour development as well as therapy. In this Review, we outline the principal cellular and molecular pathways that coordinate the tumour-promoting and tumour-antagonizing effects of inflammation and we discuss the crosstalk between cancer development and inflammatory processes. In addition, we discuss the recently suggested role of commensal microorganisms in inflammation-induced cancer and we propose that understanding this microbial influence will be crucial for targeted therapy in modern cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the intestinal microbiota can promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015), it can exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and enhancing the systemic anti-tumor immune response (Dzutsev et al., 2017).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Elinav et al., 2013
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Cited by
Items 601–700 of 1,001
Daitoku, N., Miyamoto, Y., Tokunaga, R., Sakamoto, Y., Hiyoshi, Y., Iwatsuki, M., Baba, Y., Iwagami, S., Yoshida, N., & Baba, H. (2018) · Anticancer Research · doi:10.21873/anticanres.12802 · Cited by 42
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
McCuaig, S., Barras, D., Mann, E. H., Friedrich, M., Bullers, S. J., Janney, A., Garner, L. C., Domingo, E., Koelzer, V. H., Delorenzi, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1086 · Cited by 42
The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
Weinberg, F. D., Dickson, R. P., Nagrath, D., & Ramnath, N. (2020) · Cancers · doi:10.3390/cancers13010013 · Cited by 42
Chen, J., Li, T., Liang, J., Huang, Q., Huang, J., Ke, Y., & Sun, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112443 · Cited by 42
Weber, C., Telerman, S. B., Reimer, A. S., Sequeira, I., Liakath‐Ali, K., Arwert, E. N., & Watt, F. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3676 · Cited by 42
The Antitumor Effects of α-Linolenic Acid
Yan, H., Zhang, S., Yang, L., Jiang, M., Xin, Y., Liao, X., Li, Y., & Lu, J. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030260 · Cited by 41
Stelma, T., & Leaner, V. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15834 · Cited by 41
Mathematical Modeling of Streptococcus pneumoniae Colonization, Invasive Infection and Treatment
Domínguez‐Hüttinger, E., Boon, N. J., Clarke, T. B., & Tanaka, R. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00115 · Cited by 41
Chen, J., Zhang, W., Wang, Y., Zhao, D., Wu, M., Fan, J., Li, J., Gong, Y., Dan, N., Yang, D., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0604-6 · Cited by 41
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review
Choi, C., Park, Y., & Lee, S. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.1.10 · Cited by 41
Diffuse splenic FDG uptake is predictive of clinical outcomes in patients with rectal cancer
Kim, S. Y., Moon, C. M., Yoon, H., Kim, B. S., Lim, J. Y., Kim, T. O., Choe, A. R., Tae, C. H., Kim, S., Jung, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35912-4 · Cited by 41
Morikawa, R., Nemoto, Y., Yonemoto, Y., Tanaka, S., Takei, Y., Oshima, S., Nagaishi, T., Tsuchiya, K., Nozaki, K., Mizutani, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.014 · Cited by 41
Liao, Y., Ying, H., Sun, F., Peng, H.-X., & Cheng, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s285129 · Cited by 41
Role of microbial dysbiosis in carcinogenesis & cancer therapies
Vimal, J., Himal, I., & Kannan, S. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1026_18 · Cited by 41
Eskandani, R., Kazempour, M., Farahzadi, R., Sanaat, Z., Eskandani, M., Adibkia, K., Vandghanooni, S., & Mokhtarzadeh, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113932 · Cited by 41
Cancer chemopreventive activity of compounds isolated from Waltheria indica
Monteillier, A., Cretton, S., Ciclet, O., Marcourt, L., Ebrahimi, S. N., Christen, P., & Cuendet, M. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.048 · Cited by 41
Biological and physical approaches on the role of piplartine (piperlongumine) in cancer
Henrique, T., Zanon, C. D. F., Girol, A. P., Stefanini, A. C. B., de Alcântara-Contessoto, N. S., da Silveira, N. J. F., Bezerra, D. P., Silveira, E. R., Barbosa‐Filho, J. M., Cornélio, M. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78220-6 · Cited by 40
Yang, D., Yang, L., Cai, J., Li, H., Zheng, X., & Hou, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04461-w · Cited by 40
Lai, H., Liu, Y., Wu, J., Cai, J., Hui, J., Xu, Y., & Deng, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1078766 · Cited by 40
Tacconi, S., Vari, F., Sbarigia, C., Vardanyan, D., Longo, S., Mura, F., Angilè, F., Jalabert, A., Blangero, F., Eljaafari, A., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01560-7 · Cited by 40
IL ‐17A‐producing CD 30+ Vδ1 T cells drive inflammation‐induced cancer progression
Kimura, Y., Nagai, N., Tsunekawa, N., Sato‐Matsushita, M., Yoshimoto, T., Cua, D. J., Iwakura, Y., Yagita∥, H., Okada, F., Tahara, H., et al. (2016) · Cancer Science · doi:10.1111/cas.13005 · Cited by 41
Khoo, B. L., Grenci, G., Lim, J. S. Y., Lim, Y. P., Fong, J., Yeap, W. H., Lim, S. B., Chua, S. L., Wong, S. C., Yap, Y. S., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0301-9 · Cited by 40
Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer
Zenan, H., Li, Z., Yao, Z., Huang, M. J., Yang, X., Tiantian, W., Min, D., Renbin, L., & Jia, C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28662 · Cited by 40
Inflammatory pathway interactions and cancer multidrug resistance regulation
Mirzaei, S. A., Dinmohammadi, F., Alizadeh, A., & Elahian, F. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116825 · Cited by 40
High-content and high-throughput identification of macrophage polarization phenotypes
Geng, Y., Hardie, J. M., Landis, R. F., Mas‐Rosario, J. A., Chattopadhyay, A. N., Keshri, P., Sun, J., Rizzo, E. M., Gopalakrishnan, S., Farkas, M. E., et al. (2020) · Chemical Science · doi:10.1039/d0sc02792h · Cited by 40
Asadian, S., Rezaeian, N., Hosseini, L., Toloueitabar, Y., & Komasi, M. M. H. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.08.010 · Cited by 40
Chen, J., Wang, Y., Zhang, W., Zhao, D., Zhang, L., Zhang, J., Fan, J., & Zhan, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.472 · Cited by 40
Exploring the Oncogenic Role of the Tumor “Suppressor” Oncostatin M (OSM)
Chen, M., Ren, R., Lin, W., Xiang, L., Zhao, Z., & Shao, B. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02260-9 · Cited by 40
Bergandi, L., Apprato, G., & Silvagno, F. (2022) · Antioxidants · doi:10.3390/antiox11020201 · Cited by 41
Tumor-promoting inflammation in lung cancer: A literature review
Khusnurrokhman, G., & Wati, F. F. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104022 · Cited by 40
IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity
Bahri, R., Pateras, I. S., D’Orlando, O., Goyeneche-Patino, D. A., Campbell, M., Polansky, J. K., Sandig, H., Papaioannou, M. D., Evangelou, K., Foukas, P. G., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1002721 · Cited by 40
BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer
Chao, A., Tsai, C.-L., Jung, S.-M., Chuang, W.-C., Kao, C., Hsu, A., Chen, S., Lin, C.-Y., Lee, Y., Lee, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133081 · Cited by 40
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
Chung, S. T. M., Geerts, D., Roseman, K., Renaud, A., & Connelly, L. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0606-y · Cited by 40
Evolution of Premalignant Disease
Curtius, K., Wright, N. A., & Graham, T. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026542 · Cited by 40
Wen, W., Wu, P., Li, J., Wang, H., Sun, J. M., & Chen, H. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1636-y · Cited by 40
Lee, J. M., Lee, H. S., Hyun, J. J., Choi, H. S., Kim, E. S., Keum, B., Seo, Y. S., Jeen, Y. T., Chun, H. J., Um, S. H., et al. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i7.555 · Cited by 39
Ding, N., Maiuri, A. R., & O’Hagan, H. M. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.09.005 · Cited by 39
Ventriglia, J., Petrillo, A., Huerta, M., Laterza, M. M., Savastano, B., Gambardella, V., Tirino, G., Pompella, L., Diana, A., Iovino, F., et al. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/2373868 · Cited by 39
Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis
Pang, X., Tang, Y.-J., Ren, X., Chen, Q., Tang, Y., & Liang, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01353 · Cited by 39
Activity and Functional Importance of Helicobacter pylori Virulence Factors
Sgouras, D. N., Tegtmeyer, N., & Weßler, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_358 · Cited by 39
Elsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 39
Engelmann, D., & Pützer, B. M. (2014) · Science Signaling · doi:10.1126/scisignal.2005699 · Cited by 39
Nam, S., Chang, H. R., Jung, H. R., Gim, Y., Kim, N. Y., Grailhe, R., Seo, H. R., Park, H. S., Balch, C., Lee, J., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.038 · Cited by 39
RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival
Zhang, L., Blackwell, K., Workman, L. M., Chen, S., Pope, M. R., Janz, S., & Habelhah, H. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00692-15 · Cited by 39
Huang, Y., Cai, T., Xia, X., Cai, Y.-J., & Wu, X. Y. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3sg7k · Cited by 39
Ma, X., Meng, Z., Jin, L., Xiao, Z., Wang, X., Tsark, W. M. K., Ding, L., Gu, Y., Zhang, J., Kim, B., et al. (2017) · Oncogene · doi:10.1038/onc.2017.16 · Cited by 39
Kanda, Y., Osaki, M., & Okada, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040867 · Cited by 39
Bozorgmehr, N., Okoye, I., Mashhouri, S., Lu, J., Koleva, P. T., Walker, J. W. T., & Elahi, S. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006595 · Cited by 38
Zhou, J., Wei, S., Guo, X., Huang, Y., Zhang, Y., Hong, Y., Chen, X., Lu, M., Zheng, F., & Zheng, C. (2023) · BMC Cancer · doi:10.1186/s12885-023-11752-y · Cited by 38
Mammary tissue microenvironment determines T cell‐dependent breast cancer‐associated inflammation
Takahashi, K., Nagai, N., Ogura, K., Tsuneyama, K., Saiki, I., Irimura, T., & Hayakawa, Y. (2015) · Cancer Science · doi:10.1111/cas.12685 · Cited by 38
Lee, J. W., Lee, M., Chung, I. K., Son, M. W., Cho, Y. S., & Lee, S. M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i13.2385 · Cited by 38
The Role of Tumor Necrosis Factor Alpha (TNFα) in Hearing Loss and Vestibular Schwannomas
Ren, Y., & Stanković, K. M. (2018) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-018-0186-4 · Cited by 38
Mao, Y., Chen, D., Duan, S., Zhao, Y., Wu, C., Zhu, F., Chen, C., & Chen, Y. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0698-5 · Cited by 39
RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
Gabriela-Freitas, M., Pinheiro, J., Raquel‐Cunha, A., Cardoso‐Carneiro, D., & Martinho, O. (2019) · Biomolecules · doi:10.3390/biom9120769 · Cited by 39
TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity
Lian, Q., Yan, S., Yin, Q., Yan, C., Zheng, W., Gu, W., Zhao, X., Fan, W., Li, X., Ma, L., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0366-2 · Cited by 38
Prognostic and predictive value of an immune infiltration signature in diffuse lower-grade gliomas
Song, L., Weng, J., Li, C.-B., Huo, X., Li, H., Hao, S., Wu, Z., Wang, L., Li, D., & Zhang, J.-T. (2020) · JCI Insight · doi:10.1172/jci.insight.133811 · Cited by 38
Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
Yan, S.-B., Fang, J., Chen, Y., Xie, Y., Zhang, S., Zhu, X., & Fang, F. (2020) · BMC Cancer · doi:10.1186/s12885-020-07695-3 · Cited by 38
Singh, D., Khan, M. A., & Siddique, H. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120008 · Cited by 38
Fighting Cancer with Bacteria and Their Toxins
Trivanović, D., Pavelić, K., & Peršurić, Ž. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312980 · Cited by 39
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer
Qureshy, Z., Li, H., Zeng, Y., Rivera, J. M., Cheng, N., Peterson, C. N., Kim, M., Ryan, W. R., Ha, P. K., Bauman, J. E., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0744 · Cited by 38
Granada, C. N. P., & Rodriguez‐Waitkus, P. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.07.005 · Cited by 38
Zhang, F., Huang, M., Zhou, H., Chen, K., Jin, J., Wu, Y., Ying, L., Ding, X., Su, D., & Zou, D. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07655-7 · Cited by 38
Gut microbiota imbalance and base excision repair dynamics in colon cancer
Ray, D., & Kidane, D. (2016) · Journal of Cancer · doi:10.7150/jca.15480 · Cited by 37
“The second mechanism will likely occur when the dysbiotic microbiota provoke chronic inflammation to initiate DNA damage and cellular transformation [34-36].”
BackgroundGao, W., Wang, Y., Zheng, Y., & Cai, X. (2024) · Accounts of Materials Research · doi:10.1021/accountsmr.3c00260 · Cited by 37
Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)
Wang, Z., Chang, Y., Sun, H., Li, Y., & Tang, T. (2024) · Oncology Letters · doi:10.3892/ol.2024.14390 · Cited by 37
Knaack, S., Siahpirani, A. F., & Roy, S. (2014) · Cancer Informatics · doi:10.4137/cin.s14058 · Cited by 38
Zhou, B., Zhan, C., Wu, J., Liu, J., Zhou, J., & Zheng, S. (2017) · Medical Science Monitor · doi:10.12659/msm.907182 · Cited by 37
Pediatric cancer research: Surviving COVID‐19
Auletta, J. J., Adamson, P. C., Agin, J., Kearns, P. R., Kennedy, S., Kieran, M. W., Ludwinski, D., Knox, L., McKay, K., Rhiner, P., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28435 · Cited by 37
IL-34, IL-36 and IL-38 in colorectal cancer—key immunoregulators of carcinogenesis
Bao, S., Hu, R., & Hambly, B. D. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00726-0 · Cited by 37
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 38
Peng, D., Liu, X., Cheng, Y.-X., Tao, W. Y., & Cheng, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.694997 · Cited by 37
Yu, Y., Thonn, V., Patankar, J. V., Thoma, O., Waldner, M. J., Zielińska, M., Bao, L., González-Acera, M., Wallmüller, S., Engel, F. B., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04483-0 · Cited by 37
Kim, S., Shin, M. W., Seo, S. Y., & Kim, S. W. (2022) · Bioscience Reports · doi:10.1042/bsr20212418 · Cited by 37
Burcher, K. M., Burcher, J. T., Inscore, L., Bloomer, C. H., Furdui, C. M., & Porosnicu, M. (2022) · Cancers · doi:10.3390/cancers14174116 · Cited by 37
Chen, B., Xi, Y., Zhao, J., Hong, Y., Tian, S., Zhai, X., Chen, Q., Ren, X., Fan, L., Xie, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049435 · Cited by 37
Exploration of lung mycobiome in the patients with non-small-cell lung cancer
Zhao, Y., Yi, J., Xiang, J., Jia, W. P., Chen, A., Chen, L., Zheng, L., Zhou, W. H., Wu, M., Yu, Z., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02790-4 · Cited by 37
Feng, J., Wang, L., Yang, X., Chen, Q., & Cheng, X. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14430-2 · Cited by 37
Araújo, J. E., Lodeiro, C., Capelo, J. L., Rodríguez‐González, B., Santos, A. A. D., Santos, H. M., & Fernández‐Lodeiro, J. (2014) · Nano Research · doi:10.1007/s12274-014-0599-4 · Cited by 37
Waterhouse, M. A., Tran, B. N. H., Ebeling, P. R., English, D. R., Lucas, R. M., Venn, A., Webb, P. M., Whiteman, D. C., & Neale, R. Ε. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002366 · Cited by 37
Yang, T., Chung, C., Chung, S., Muo, C., Chang, C., & Huang, C. (2015) · Medicine · doi:10.1097/md.0000000000001278 · Cited by 37
Zhu, J., Wang, H., Liu, C.-C., Lu, Y., & Tang, H. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2228-y · Cited by 37
Wu, J., Li, L., Wang, S., Pang, X., Wu, J., Sheng, S., Tang, Y., Tang, Y., Zheng, M. H., & Liang, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6747 · Cited by 37
Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB
Xie, B., Cao, K., Li, J., Chen, J., Tang, J., Chen, X., Xia, K., Zhou, X., Cheng, Y., Zhou, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12623 · Cited by 36
Pang, Q., Jin, H., Qu, K., Man, Z., Wang, Y., Yang, S., Zhou, L., & Liu, H. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s143154 · Cited by 36
Vokálová, L., van Breda, S. V., Ye, X. L., Huhn, E. A., Than, N. G., Hasler, P., Lapaire, O., Hoesli, I. M., Rossi, S. W., & Hahn, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00542 · Cited by 36
Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
Xie, C., Zhu, J., Wang, X., Chen, J., Geng, S., Wu, J., Zhong, C., & Li, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1052-z · Cited by 36
Agrawal, B. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0241-x · Cited by 36
Biological Properties of a Citral-Enriched Fraction of Citrus limon Essential Oil
Pucci, M., Raimondo, S., Zichittella, C., Tinnirello, V., Corleone, V., Aiello, G., Moschetti, M., Conigliaro, A., Fontana, S., & Alessandro, R. (2020) · Foods · doi:10.3390/foods9091290 · Cited by 36
Hong, Y. M., Yoon, K. T., & Cho, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-08124-9 · Cited by 36
Song, X., Zhang, H., Yin, F., Guo, P., Yang, X., Liu, J., Han, Y., & Ren, Z. (2021) · Mediators of Inflammation · doi:10.1155/2021/3456629 · Cited by 36
Biomimetic approaches for targeting tumor-promoting inflammation
Parodi, A., Kostyushev, D. S., Brezgin, S. A., Kostyusheva, A. P., Borodina, T. N., Akasov, R., Frolova, A. S., Chulanov, V., & Zamyatnin, A. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.007 · Cited by 36
Costache, D. O., Feroiu, O., Ghilencea, A. F., Georgescu, M., Căruntu, A., Căruntu, C., Ţiplica, G., Jinga, M., & Costache, R. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095198 · Cited by 36
Induction of pyroptotic cell death as a potential tool for cancer treatment
Faria, S. S., Fernando, A. J., de Lima, V. C. C., Rossi, A. G., de Carvalho, J. M. A., & Magalhães, K. G. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00316-9 · Cited by 36
He, J., Tong, L., Wu, P., Wu, Y., Shi, W., & Chen, L. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s396871 · Cited by 36
Xun, J., Zhou, S., Lv, Z., Wang, B., Luo, H., Zhang, L., Yang, L., Zhang, A., Wu, X., Wang, Z., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109839 · Cited by 36
Hackler, P. C., Reuss, S., Konger, R. L., Travers, J. B., & Sahu, R. P. (2014) · Cancer Growth and Metastasis · doi:10.4137/cgm.s14501 · Cited by 36
Anti-Inflammatory Effects of Chloranthalactone B in LPS-Stimulated RAW264.7 Cells
Li, X., Shen, J., Jiang, Y., Shen, T., You, L., Sun, X., Xu, X., Hu, W., Wu, H., & Wang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111938 · Cited by 36
Zhao, L., Zhang, X., Zuo, T., & Yu, J. Q. (2017) · Engineering · doi:10.1016/j.eng.2017.01.012 · Cited by 36
Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells
Ding, X., Zhang, W., Zhao, T., Yan, C., & Du, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16280 · Cited by 36
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.005 · Cited by 36
Metadata
- Authors
- Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A.
- Affiliations
- Weizmann Institute of Science (IL)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Elinav, Eran
- Flavell, Richard A.
- Venue
- Nature reviews. Cancer
- Published
- 2013-10-24
- Volume
- 13
- Issue
- 11
- Pages
- 759-771
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2143841612
- Cited by
- 2,000
- References
- 154
- Citations by year
- 2026: 83 · 2025: 150 · 2024: 223 · 2023: 167 · 2022: 204 · 2021: 187 · 2020: 202 · 2019: 132 · 2018: 144 · 2017: 149 · 2016: 142 · 2015: 124 · 2014: 90 · 2013: 2
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammation-associated tumorigenesis, chronic inflammation, tumor progression, tumor microenvironment, gut microbiota, commensal microorganisms, innate immunity, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Homeostasis, Humans, Immunity, Innate, Inflammation, Neoplasm Metastasis, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Cell Proliferation, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.